Cargando…
Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
Intestinal barrier injury and hyperglycemia are common in patients with sepsis. Bacteria translocation and systemic inflammatory response caused by intestinal barrier injury play a significant role in sepsis occurrence and deterioration, while hyperglycemia is linked to adverse outcomes in sepsis. P...
Autores principales: | Wang, Yi-Feng, Li, Jia-Wei, Wang, Da-Peng, Jin, Ke, Hui, Jiao-Jie, Xu, Hong-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176233/ https://www.ncbi.nlm.nih.gov/pubmed/35693534 http://dx.doi.org/10.2147/DDDT.S360348 |
Ejemplares similares
-
Synthesis and Evaluation of Novel Pyrroles and Pyrrolopyrimidines as Anti-Hyperglycemic Agents
por: Mohamed, M. S., et al.
Publicado: (2014) -
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
por: Sekhar, Kuruva Chandra, et al.
Publicado: (2014) -
New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes
por: Chen, Yanxia, et al.
Publicado: (2021) -
Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives
por: Naimi, Madina, et al.
Publicado: (2017) -
Safety and anti-hyperglycemic efficacy of various tea types in mice
por: Han, Manman, et al.
Publicado: (2016)